Yahoo
NasdaqCM - Nasdaq Real Time Price USD

InMed Pharmaceuticals Inc. (INM)

1.6000 -0.0250 (-1.54%)
At close: October 30 at 4:00:00 PM EDT
1.5700 -0.0300 (-1.87%)
Pre-Market: 8:21:04 AM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
6/30/2026
6/30/2025
6/30/2024
6/30/2023
Total Revenue
0
0
0
4,597.7300
4,135.5610
Cost of Revenue
--
--
3,236.0470
3,496.8170
2,732.5250
Gross Profit
--
--
1,706.5860
1,100.9130
1,403.0360
Operating Expense
9,895.1160
9,895.1160
8,446.1700
--
--
Operating Income
-9,895.1160
-9,895.1160
-8,446.1700
-8,134.4300
-8,378.7870
Net Non Operating Interest Income Expense
234.2710
234.2710
-215.6670
527.9010
492.4400
Other Income Expense
-1,712.2960
-1,712.2960
-28.4710
-61.9210
-48.1750
Pretax Income
-11,373.1410
-11,373.1410
-8,690.3080
-7,668.4500
-7,934.5220
Tax Provision
0
0
0
7.1000
13.1000
Net Income Common Stockholders
-12,560.8500
-12,560.8500
-8,162.1330
-7,675.5500
-7,947.6220
Diluted NI Available to Com Stockholders
-12,560.8500
-12,560.8500
-8,162.1330
-7,675.5500
-7,947.6220
Basic EPS
-2.12
-3.12
-8.36
-20.20
-65.00
Diluted EPS
-2.12
-3.12
-8.36
-20.20
-65.00
Basic Average Shares
3,362.0380
4,163.5980
975.8950
381.0530
122.4220
Diluted Average Shares
3,362.0380
4,163.5980
975.8950
381.0530
122.4220
Total Expenses
9,895.1160
9,895.1160
8,446.1700
12,732.1600
12,514.3480
Net Income from Continuing & Discontinued Operation
-12,560.8500
-12,560.8500
-8,162.1330
-7,675.5500
-7,947.6220
Normalized Income
-9,660.8450
-9,660.8450
-8,661.8370
-7,622.9172
-7,918.7170
Interest Income
244.9710
244.9710
155.8820
527.9010
492.4400
Interest Expense
10.7000
10.7000
371.5490
0
--
Net Interest Income
234.2710
234.2710
-215.6670
527.9010
492.4400
EBIT
-11,362.4410
-11,362.4410
-8,318.7590
-7,668.4500
-8,378.7870
EBITDA
-10,654.0850
-10,654.0850
-7,784.0350
-7,063.9320
-7,782.7900
Reconciled Cost of Revenue
--
--
2,914.1610
3,111.8990
2,338.7770
Reconciled Depreciation
708.3560
708.3560
534.7240
604.5180
595.9970
Net Income from Continuing Operation Net Minority Interest
-11,373.1410
-11,373.1410
-8,690.3080
-7,675.5500
-7,947.6220
Total Unusual Items Excluding Goodwill
-1,712.2960
-1,712.2960
-28.4710
-61.9210
-48.1750
Total Unusual Items
-1,712.2960
-1,712.2960
-28.4710
-61.9210
-48.1750
Normalized EBITDA
-8,941.7890
-8,941.7890
-7,755.5640
-7,002.0110
-7,734.6150
Tax Rate for Calcs
0
0
0
0.0002
0.0004
Tax Effect of Unusual Items
0
0
0
-9.2882
-19.2700
6/30/2023 - 5/5/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: